p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme

被引：0
|
作者：
Jiao Meng
Wei Qian
Zhenkun Yang
Lingli Gong
Daxing Xu
Hongbo Huang
Xinyi Jiang
Zhening Pu
Ying Yin
Jian Zou
机构：
[1] The Affiliated Wuxi People’s Hospital of Nanjing Medical University,Department of Laboratory Medicine, Wuxi People’s Hospital, Wuxi Medical Center
[2] Nanjing Medical University,Center of Clinical Research, Wuxi People’s Hospital, Wuxi Medical Center
[3] The Affiliated Wuxi People’s Hospital of Nanjing Medical University,NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine
[4] Nanjing Medical University, Department of Clinical Laborator
[5] Jiangsu Institute of Nuclear Medicine,undefined
[6] Kunshan Hospital of Traditional Chinese Medicine,undefined
[7] Kunshan,undefined
来源：
BMC Cancer | / 24卷
关键词：
E2F7; p53; Chemoresistance; Temozolomide; Glioblastoma multiforme;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
    Meng, Jiao
    Qian, Wei
    Yang, Zhenkun
    Gong, Lingli
    Xu, Daxing
    Huang, Hongbo
    Jiang, Xinyi
    Pu, Zhening
    Yin, Ying
    Zou, Jian
    BMC CANCER, 2024, 24 (01)
  • [2] WNT signaling modulates chemoresistance to temozolomide in p53-mutant glioblastoma multiforme
    Zhourui Ma
    Shizhong Cai
    Qianwei Xiong
    Wei Liu
    Hongliang Xia
    Zhenhong Zhu
    Zhijian Huang
    Xiangming Yan
    Qian Wang
    Apoptosis, 2022, 27 : 80 - 89
  • [3] WNT signaling modulates chemoresistance to temozolomide in p53-mutant glioblastoma multiforme
    Ma, Zhourui
    Cai, Shizhong
    Xiong, Qianwei
    Liu, Wei
    Xia, Hongliang
    Zhu, Zhenhong
    Huang, Zhijian
    Yan, Xiangming
    Wang, Qian
    APOPTOSIS, 2022, 27 (1-2) : 80 - 89
  • [4] A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme
    Kim, Sang-Soo
    Rait, Antonina
    Kim, Eric
    Pirollo, Kathleen F.
    Chang, Esther H.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (02) : 301 - 311
  • [5] Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells
    Wu, Lei
    Yang, Liang
    Xiong, Yu
    Guo, Hua
    Shen, Xiaoli
    Cheng, Zujue
    Zhang, Yan
    Gao, Ziyun
    Zhu, Xingen
    TUMOR BIOLOGY, 2014, 35 (12) : 12327 - 12337
  • [6] The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence
    Aksoy, Ozlem
    Chicas, Agustin
    Zeng, Tianying
    Zhao, Zhen
    McCurrach, Mila
    Wang, Xiaowo
    Lowe, Scott W.
    GENES & DEVELOPMENT, 2012, 26 (14) : 1546 - 1557
  • [7] E2F7−EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression
    Rui Yang
    Mei Wang
    Guanghui Zhang
    Yonghua Bao
    Yanan Wu
    Xiuxiu Li
    Wancai Yang
    Hongjuan Cui
    British Journal of Cancer, 2020, 123 : 1445 - 1455
  • [8] Integrins and p53 pathways in glioblastoma resistance to temozolomide
    Martin, Sophie
    Janouskova, Hana
    Dontenwill, Monique
    FRONTIERS IN ONCOLOGY, 2012, 2
  • [9] Role of p53 in TRAIL-induced apoptosis in glioblastoma multiforme and modulation by taxol, rapamycin or temozolomide
    Dorsey, Jay F.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2006, 66 (08)
  • [10] BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53
    Er Nie
    Xin Jin
    Weining Wu
    Tianfu Yu
    Xu Zhou
    Tongle Zhi
    Zhumei Shi
    Junxia Zhang
    Ning Liu
    Yongping You
    Scientific Reports, 6
12345